RxSight, Inc.
US ˙ NasdaqGM ˙ US78349D1072

SecurityRXST / RxSight, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership62,053 shares
Latest Disclosed Value $ 806,689
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in RXST / RxSight, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 62,053 shares of RxSight, Inc. (US:RXST) valued at $806,689 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 62,053 shares of RxSight, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $310,265 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP RxSight EC US78349D1072 62,053 0 0.00 807 -48.53 0.0181
2025-05-28 2025-03-31 NP RxSight EC US78349D1072 62,053 124 0.20 1,567 -26.44 0.0376
2025-02-25 2024-12-31 NP RxSight EC US78349D1072 61,929 -5,453 -8.09 2,129 -36.07 0.0465
2024-11-26 2024-09-30 NP RxSight EC US78349D1072 67,382 13,495 25.04 3,331 2.71 0.0630
2024-08-26 2024-06-30 NP RxSight EC US78349D1072 53,887 4,336 8.75 3,242 26.89 0.0660
2024-05-28 2024-03-31 NP RxSight EC US78349D1072 49,551 0 0.00 2,556 27.94 0.0533
2024-02-26 2023-12-31 NP RxSight EC US78349D1072 49,551 3,052 6.56 1,998 54.09 0.0426
2023-11-28 2023-09-30 NP RxSight EC US78349D1072 46,499 -706 -1.50 1,297 -4.64 0.0338
2023-08-25 2023-06-30 NP RxSight EC US78349D1072 47,205 10,458 28.46 1,360 122.06 0.0322
2023-05-26 2023-03-31 NP RxSight EC US78349D1072 36,747 2,961 8.76 613 42.99 0.0163
2023-02-24 2022-12-31 NP RxSight EC US78349D1072 33,786 0 0.00 428 5.68 0.0118
2022-11-25 2022-09-30 NP RxSight EC US78349D1072 33,786 2,649 8.51 405 -7.53 0.0116
2022-08-25 2022-06-30 NP RxSight EC US78349D1072 31,137 9,019 40.78 438 60.44 0.0121
2022-05-26 2022-03-31 NP RxSight EC US78349D1072 22,118 9,954 81.83 274 100.74 0.0064
2022-02-25 2021-12-31 NP RxSight EC US78349D1072 12,164 0 0.00 137 -11.69 0.0030
2021-11-24 2021-09-30 NP RxSight EC US78349D1072 12,164 12,164 154 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.